by Sue Robbins | Apr 12, 2021 | Miscellaneous
Worldwide, 1 in 4 people will suffer from a depressive episode in their lifetime. While current diagnosis and treatment approaches are largely trial and error, a breakthrough study by Indiana University School of Medicine researchers sheds new light on the biological...
by Sue Robbins | Jan 26, 2021 | Miscellaneous
Researchers found that levels of a nerve growth factor were lower in people with depression or bipolar disorder than in healthy controls. Doctors could potentially use levels of the growth factor to monitor the effects of antidepressant treatment. In adults, a protein...
by Sue Robbins | May 20, 2020 | Miscellaneous
I’ve been pouring over textbooks and treatment guidelines, and these four mood stabilizers keep rising to the top.1-6 None of them are perfect, but each has a unique role in bipolar disorder: Lithium Quetiapine (Seroquel) Lurasidone (Latuda) Lamotrigine (Lamictal)...
by Sue Robbins | Mar 15, 2015 | Headache Drugs
The first study to examine the use of cannabis in the context of daily life among people with Bipolar Disorder has shown how the drug is linked to increases in both manic and depressive symptoms. Dr. Elizabeth Tyler of the Spectrum Centre for Mental Health Research at...
by Sue Robbins | Aug 12, 2013 | Headache Drugs
The following is an excerpt of an article by Juliann Garey, recently published in The New York Times. Garey is the author of the novel “Too Bright to Hear Too Loud to See” and a co-editor of “Voices of Bipolar Disorder: The Healing Companion.”...
